GEMSEKI

  • Drug Candidate Marketplace
  • About
    About Gemseki Message Members What is Licensing
  • Service
    Fund Why us? How it Works?
  • News
  • Contact
  • Sign in
  • Sign up
  • JP
  • EN

News

Apr 11th, 2022
Gemseki has launched the upgraded Drug Candidate Marketplace!
We are thrilled to announce the launch of our new website and the upgraded Drug Candi...
Mar 8th, 2022
Gemseki Ventures L.P. Investment in Toregem BioPharma Co., Ltd.
Gemseki Ventures L.P. is pleased to announce our investment in Toregem BioPharma Co.,...
Jan 11th, 2022
Gemseki Ventures L.P. Investment in Cellusion Inc.
Gemseki Ventures L.P. is pleased to announce our investment in Cellusion Inc. Cellusi...
Dec 17th, 2021
Notice of Office Closure for New Year’s Holiday
Dear client, We’d like to inform you Gemseki’s office closure for the New Year’s Holi...
Sep 9th, 2021
Gemseki Ventures L.P. Investment in PRISM BioLab
Gemseki Ventures L.P. is pleased to announce our investment in PRISM BioLab. PRISM Bi...
Jul 28th, 2021
An Online presentation at Oregon Bioscience Incubator
Our VP of Business Development, Sanjeev Balhara, made a presentation of “Accelerating...
Jun 1st, 2021
Gemseki Ventures L.P. Investment in Curreio
Gemseki Ventures L.P. is pleased to announce our investment in Curreio. Curreio is a...
Mar 1st, 2021
Gemseki Ventures L.P. Invests in Cardio Intelligence
Gemseki Ventures L.P. is pleased to announce our first investment, acquiring shares f...
1
2
3
4
5

About

  • About Gemseki
  • Message
  • Members
  • What is Licensing

Service

  • Drug Candidate Marketplace
  • Fund
  • Why us?
  • How it Works?

News

  • News
Sign up
Contact
  • GEMSEKI
  • SNBL
  • Linkedin
copyright © Gemseki Inc. All Rights Reserved.
  • Privacy Policy
  • Term of Use